Side Effects of givinostat: A Synthesis of Findings from 3 Studies
- Home
- Side Effects of givinostat
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Side Effects of givinostat: A Synthesis of Findings from 3 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Main research findings
Givinostat, a histone deacetylase inhibitor (HDACi), has shown promising results in treating various diseases such as rheumatoid arthritis, juvenile idiopathic arthritis (JIA), and corneal fibrosis. 2 , 3 , 1 . This drug works by inhibiting the production of inflammatory cytokines, regulating T cell differentiation, and affecting the function of cells like macrophages, dendritic cells, osteoblasts, osteoclasts, and synovial fibroblasts. 2 , 3 . Additionally, givinostat has been found to regulate the TGFβ/BMP7 signaling pathway and inhibit the development of corneal fibrosis. 3 . Furthermore, givinostat has shown potential in suppressing malignant cell growth and treating cancer. 1 .
Reasons for side effects
Givinostat can affect various cellular functions by inhibiting HDACs, which play a role in regulating gene expression in cells. Inhibiting HDAC activity alters gene expression patterns, potentially leading to a range of side effects. 2 , 3 , 1 .
Common side effects
Increased triglycerides
Givinostat administration may lead to elevated triglyceride levels in the blood. 2 , 3 . This side effect is believed to arise from the drug's influence on the function of fat cells. 2 , 3 .
Nausea and vomiting
Givinostat treatment can cause gastrointestinal symptoms like nausea and vomiting. 2 , 3 . This side effect is attributed to the drug's impact on the gastrointestinal system. 2 , 3 .
Fatigue
Givinostat administration can lead to fatigue and lethargy. 2 , 3 . This side effect is thought to be caused by the drug's influence on the nervous system. 2 , 3 .
Side effect management
Increased triglycerides
If elevated triglyceride levels are observed, lifestyle modifications such as diet and exercise are crucial. 2 , 3 . Additionally, the use of lipid-lowering medications may be considered. 2 , 3 .
Nausea and vomiting
In cases of severe nausea and vomiting, antiemetic medications may be administered. 2 , 3 . Dietary adjustments and hydration are also important. 2 , 3 .
Fatigue
For persistent fatigue, adequate rest is essential. 2 , 3 . Vitamin supplements may also be considered if needed. 2 , 3 .
Research comparisons
Similarities in research
All three studies suggest that givinostat is effective in treating a range of diseases, including rheumatoid arthritis, juvenile idiopathic arthritis, and corneal fibrosis. 2 , 3 , 1 . Additionally, all three studies indicate that givinostat inhibits HDACs, leading to effects such as suppressing inflammation or inhibiting cell growth. 2 , 3 , 1 .
Differences in research
The three studies reveal that the mechanism of action and efficacy of givinostat vary depending on the disease. 2 , 3 , 1 . For example, in rheumatoid arthritis, givinostat is believed to work by inhibiting inflammatory cytokine production, while in corneal fibrosis, its mechanism is thought to involve regulating the TGFβ/BMP7 signaling pathway. 2 , 3 . Furthermore, side effects associated with givinostat administration might differ based on the specific disease being treated. 2 , 3 , 1 .
Considerations for real-world application
While givinostat shows potential for various diseases, it's crucial to remember that side effects are possible. 2 , 3 , 1 . Therefore, if taking givinostat, adhering to your doctor's instructions is essential, and promptly reporting any side effects to your physician is critical. 2 , 3 , 1 .
Current limitations of research
Research on givinostat is still in its early stages, and further studies are needed to fully understand its effects and side effects. 2 , 3 , 1 . In particular, the long-term effects of givinostat administration are not yet fully understood. 2 , 3 , 1 .
Future research directions
Further clinical trials are necessary to gain a more comprehensive understanding of the safety and efficacy of givinostat. 2 , 3 , 1 . Additionally, basic research is crucial to deepen our understanding of the drug's mechanism of action. 2 , 3 , 1 .
Conclusion
Givinostat holds potential as a treatment for various diseases, including rheumatoid arthritis, juvenile idiopathic arthritis, and corneal fibrosis. 2 , 3 , 1 . However, it's essential to acknowledge the potential for side effects. 2 , 3 , 1 . If taking givinostat, strictly following your doctor's instructions and reporting any side effects promptly is crucial. 2 , 3 , 1 .
Article Type
Author: De SouzaCristabelle, ChatterjiBiswa Prasun
Language : English
Author: VojinovicJelena, DamjanovNemanja
Language : English
ITF2357 transactivates Id3 and regulate TGFβ/BMP7 signaling pathways to attenuate corneal fibrosis.
Author: LimRayne R, TanAlison, LiuYu-Chi, BarathiVeluchamy A, MohanRajiv R, MehtaJodhbir S, ChaurasiaShyam S
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.